News

For the first time in Colombia, patients with refractory epilepsy will be able to receive treatment with cannabis-based medicine. This new drug is the first and only INVIMA approved pharmaceutical grade Cannabidiol with scientific support.

The orientation towards innovation and the vision to contribute to solving health challenges has allowed Procaps to be a company permanently motivated to contribute to the construction of a healthier world.

Procaps, always committed to the well-being and health of all people, celebrates the findings of the mentioned research, while through the efforts of the Organization, it can contribute to the generation of products such as dexamethasone that allow recovery of patients severely affected by the coronavirus.

Know the postponed trade shows where we had a participation in first semester